Pressure Ulcers Pipeline (Dermatology) H1 2017 Market Landscape Report at

Pressure Ulcers Pipeline Market Report H1 2017 report provides an overview of the Pressure Ulcers (Dermatology) pipeline landscape. The Pressure Ulcers Pipeline guide encapsulates all the dormant and discontinued pipeline projects.

Market pipeline report Pressure Ulcers - Pipeline Review, H1 2017 key players involved in therapeutic development for Pressure Ulcers and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II and Preclinical stages are 3 and 5 respectively.

Pressure Ulcers Pipeline report has 6 Company Profiles, 15 Tables and 9 Figures, Spread across 37 Pages Report Available at .

Pressure ulcers are an injury that breaks down the skin and underlying tissue. The parts of the body most at risk of developing pressure ulcers are those that are not covered by a large amount of body fat and are in direct contact with a supporting surface (bed or a wheelchair). Causes include continuous pressure, friction and shear. Treatment includes antibiotics and nutrition.

Pressure Ulcers - Companies Involved in Therapeutics Development: EyeGene Inc, Izun Pharmaceuticals Corp, MediWound Ltd, NovaLead Pharma Pvt Ltd, RegeneRx Biopharmaceuticals Inc, RMB-Research GmbH

Order a copy of this research report at

Pressure Ulcers - Drug Profiles : AG-100, EG-Decorin, EscharEx, IZN-6D4, NLP-328, RGN-137, Statmicoll, Stem Cell Therapy, Stem Cell Therapy

The Pressure Ulcers Pipeline guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Pressure Ulcers (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope : The pipeline guide provides a snapshot of the global therapeutic landscape of Pressure Ulcers (Dermatology). The pipeline guide reviews pipeline therapeutics for Pressure Ulcers (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. The pipeline guide reviews key companies involved in Pressure Ulcers (Dermatology) therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Pressure Ulcers (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. The pipeline guide encapsulates all the dormant and discontinued pipeline projects. The pipeline guide reviews latest news related to pipeline therapeutics for Pressure Ulcers (Dermatology).

Related Report
Aphthous Ulcers (Canker Sores) Global Clinical Trials Review, H1, 2017 : The report, "Aphthous Ulcers (Canker Sores) Global Clinical Trials Review, H1, 2017" provides an overview of Aphthous Ulcers (Canker Sores) clinical trials scenario. This report provides top line data relating to the clinical trials on Aphthous Ulcers (Canker Sores). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. Call +1 888 391 5441 with your research requirements or email the details at

Contact Info:
Name: Ritesh Tiwari
Email: Send Email

Release ID: 207716